Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan/Feb;11(1):3-9.
doi: 10.1097/ADM.0000000000000260.

Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System

Affiliations

Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System

Amber L Bahorik et al. J Addict Med. 2017 Jan/Feb.

Abstract

Objectives: We examined prevalence of major medical conditions and extent of disease burden among patients with and without substance use disorders (SUDs) in an integrated health care system serving 3.8 million members.

Methods: Medical conditions and SUDs were extracted from electronic health records in 2010. Patients with SUDs (n = 45,461; alcohol, amphetamine, barbiturate, cocaine, hallucinogen, and opioid) and demographically matched patients without SUDs (n = 45,461) were compared on the prevalence of 19 major medical conditions. Disease burden was measured as a function of 10-year mortality risk using the Charlson Comorbidity Index. P-values were adjusted using Hochberg's correction for multiple-inference testing within each medical condition category.

Results: The most frequently diagnosed SUDs in 2010 were alcohol (57.6%), cannabis (14.9%), and opioid (12.9%). Patients with these SUDs had higher prevalence of major medical conditions than non-SUD patients (alcohol use disorders, 85.3% vs 55.3%; cannabis use disorders, 41.9% vs 23.0%; and opioid use disorders, 44.9% vs 26.1%; all P < 0.001). Patients with these SUDs also had higher disease burden than non-SUD patients; patients with opioid use disorders (M = 0.48; SE = 1.46) had particularly high disease burden (M = 0.23; SE = 0.09; P < 0.001).

Conclusions: Common SUDs, particularly opioid use disorders, are associated with substantial disease burden for privately insured individuals without significant impediments to care. This signals the need to explore the full impact SUDs have on the course and outcome of prevalent conditions and initiate enhanced service engagement strategies to improve disease burden.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Disease burden measured as a function of 10-year mortality risk for patients with any SUD, and patients with at least one of the three most common SUDs in 2010 and their demographically matched counterparts without SUDs.

References

    1. Aldington S, Harwood B, Cox B, Weatherall M, Beckert L, Hansell A. Cannabis use and risk of lung cancer: a case—control study. Eur Respir J. 2008;31:280–286. - PMC - PubMed
    1. Barry CL, Huskamp HA. Moving beyond parity—mental health and addiction care under the ACA. N Engl J Med. 2011;356(11):973–975. - PMC - PubMed
    1. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol. 2008;3:1398–13403. - PubMed
    1. Birnbaum H, White A, Schiller M, Waldman T, Cleveland J, Roland C. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657–667. - PubMed
    1. Boyd C, Leff B, Weiss C, Wolff J, Hamblin A, Martin L. Clarifying multi-morbidity patterns to improve targeting and delivery of clinical services for Medicaid populations. Center for Health Care Strategies. Inc.; Dec, 2010.

Publication types

MeSH terms